遷延性肺高血圧症の根拠に基づく管理
1Children's Mercy Hospitals and Clinics, Kansas City, MO, USA carolrtrees@gmail.com.
Neonatal network : NN
|February 26, 2026
まとめ
新生児遷延性肺高血圧症(PPHN)の管理は複雑である。NICUにおける根拠に基づく介入バンドルは、乳児の安定化を改善し、転院を減少させる可能性がある。
科学分野:
- 新生児医学
- 小児循環器病学
- 集中治療医学
背景:
- 新生児遷延性肺高血圧症(PPHN)は、肺血管抵抗の上昇と胎児循環移行の障害を伴う。
- PPHNの管理は、複雑で多因子的な病態生理のため困難である。
- 臨床的コンセンサスと正式なガイドラインの欠如がPPHNケアを複雑にしている。
研究 の 目的:
- PPHN管理のための包括的かつ根拠に基づくアプローチを提案すること。
- 第IIIレベルNICUにおける介入バンドルの潜在的な利点を検討すること。
主な方法:
- PPHN介入に関する既存の文献のレビュー。
- 根拠に基づく介入バンドルの提案。
- 第IIIレベル新生児集中治療室(NICU)内での適用に焦点を当てる。
主要な成果:
- 重篤なPPHNを有する新生児には包括的なアプローチが不可欠である。
- 根拠に基づく介入バンドルは乳児の安定化を強化する可能性がある。
- 第IIIレベルNICUでの実施は、第IVレベルNICUへの転院を減少させる可能性がある。
結論:
- 標準化された根拠に基づくケアバンドルは、PPHN管理に不可欠である。
- そのようなバンドルの実施は、ハイリスク新生児の転帰を改善する可能性がある。
- このアプローチは、NICUレベル全体のリソース利用を最適化する可能性がある。
関連する概念動画
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
596
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
596
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
552
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
552
Pulmonary Hypertension: Classification and Pathogenesis
721
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
721
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
680
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
680
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.4K


